Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Navamedic Proxy Solicitation & Information Statement 2026

Mar 31, 2026

3668_rns_2026-03-31_a49fc68c-14a9-45eb-9d77-6f94f555a1ea.html

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

Navamedic ASA: Notice of Annual General Meeting

Navamedic ASA: Notice of Annual General Meeting

The annual general meeting of Navamedic ASA will be held on Thursday, 23 April 2026 at 15:00 (CEST) at the company’s offices at Henrik Ibsens gate 100, 0255 Oslo. Shareholders may also participate digitally or cast votes in advance.

The notice of the meeting, including the agenda as well as the notice of attendance, advance voting and proxy form, is attached to this message and is also available, together with the related attachments, at https://navamedic.com/investors/general-meeting/.

About Navamedic

Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.